ダイチョウキン　ヲ　モチイタ　N-ケツゴウガタ　トウサ　フカガタ　トウ　タンパクシツ　セイサンケイ　ノ　コウチク by スイチャイスパキット, アッカラポン & Srichaisupakit, Akkaraphol
Osaka University
TitleConstruction of an Escherichia coli System for the Productionof N-linked Glycoproteins
Author(s)Srichaisupakit, Akkaraphol
Citation
Issue Date
Text VersionETD
URL http://hdl.handle.net/11094/52182
DOI
Rights
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ????
? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??
?????
Construction of an Escherichia coli System for the Production of N-linked Glycoproteins 
???????N-????????????????????
????????
Chapter 1: Introduction 
Asparagine-linked (N-linked) protein glycosylation is an abundant protein post-translational modification mechanism by 
adding sugar moiety (generally described as glycan) onto designated amino acid sequence on the nascent polypeptide chain. 
Glycan structure varies, depend on corresponding hosts. This process is sophisticated; yet shares common mechanisms amongst 
eukaryotes and available throughout domains of life. Eukaryotic N-glycosylation was elucidated to possess variety of glycosyl 
linkages, glycan branching and complex structures. Numerous implications of protein N-glycosylation are such as for protein 
folding, oligomerization, structural stability, cellular trafficking, secretion, protease protection and cell-to-cell adhesion. In 
eukaryotes, early stage of N-glycosylation includes the synthesis of lipid-linked oligosaccharide (LLO) donor 
Glc3Man9GlcNAc2-PP-Dol (Glc, glucose; Man, mannose; GlcNAc, N-acetylglucosamine; Dol, dolichol) by dolichol pathway 
consisted of various glycosyltransferases (GTases). Oligosaccharyltransferase (OST) complex transfers oligosaccharide moiety 
from LLO onto N-X-S/T sites of nascent polypeptide chain. Moreover, N-glycosylation could be observed in archaeal organisms 
and bacteria. Campylobacter jejuni is a Gram-negative and pathogenic bacterium whose N-glycosylation pathway was most 
extensively studied. Previously, the protein glycosylation (pgl) operon of C. jejuni NCTC 81116 (Wacker et al., 2002) could be 
functionally transferred into Escherichia coli. Using advantages of the transferred pgl operon along with native components of E. 
coli, glycoengineering of glycosylation pathway, by introduction of corresponding GTases, could be performed. By this manner, a 
novel glycan structure could be synthesized in E. coli. 
Chapter 2: Cloning and Characterization of Protein Glycosylation Operon from Campylobacter jejuni JCM 2013  
C. jejuni JCM 2013 is available in the Japan Collection of Microorganisms (JCM), but there has been no report focusing 
on its protein N-glycosylation. In this study, identification of the C. jejuni JCM 2013 pgl operon was performed. CmeA protein 
from C. jejuni was chosen as a glycan acceptor protein in this work. To assess the function of the cloned pgl operon, it was 
co-expressed with CmeA, which possesses 2 prokaryotic N-glycosylation sites (D/E-X1-N-X2-S/T), in the constructed E. coli 
BL21  waaL mutant. Protein expression was successful, putative protein glycosylation activity was observed using immuno- and 
soybean agglutinin lectin-blotting. The detailed glycan structure was analyzed by mass spectrometry (MS) and the 
fluorophore-labeling method. Operon minimization and induction conditions were studied. Furthermore, maltose binding protein 
(MBP) and DsbA were C-terminally fused with synthetic glycosylation sequon and expressed as alternative glycan acceptor 
proteins. In brief, protein glycosylation of pgl operon resulted in glycan structure (Hex)-GalNAc5-GlcNAc, where protein 
glycosylation was observed on native glycosylation site of CmeA and on synthetic acceptor sites on MBP and DsbA. 
Chapter 3: Biosynthesis of an Initial-Stage Eukaryotic N-Glycan and its Protein Glycosylation in E. coli 
  To prove the principle of glycoengineering in E. coli, Man3GlcNAc2 was chosen as the desired structure to be 
synthesized. Because it is the smallest branched glycan unit observed in eukaryotes, and could accommodate further 
modifications to obtain complex-type or hybrid-type glycans. Furthermore, Man3GlcNAc2 structure was tested and found 
minimally required for clinical efficacy in delivering of therapeutic glycoprotein -glucocerebrosidase. Some GTases from 
Saccharomyces cerevisiae were shown to be solubly expressed in E. coli with in vitro activity. Therefore, S. cerevisiae was 
chosen as a source of GTase genes. To synthesize Man3GlcNAc2 in E. coli, Alg13, Alg14, Alg1 and Alg2 are required. The E. 
coli endogenous lipid-glycosyltransferase WecA helps establish the GlcNAc-PP-Und, which is required for subsequent catalytic 
steps of GTases listed above. Finally, PglB derived from C. jejuni JCM 2013, identified in Chapter 2, was used as OST. The 
glycan acceptor protein was the MBP-GT carrying synthetic prokaryotic glycosylation motif recognized by PglB. This system 
was transferred into constructed E. coli BL21  waaL gmd mutant, where GDP-Man can be accumulated as a substrate of 
mannosyltransferases Alg1 and Alg2. Protein expression and the LLO biosynthesis in the constructed system was analyzed by 
immuno-blotting and HPLC, respectively. Structure of glycan released from MBP-GT was identified. Finally, glycosylation of 
Man3GlcNAc2 synthesized from the constructed pathway was observed on glycosylation motif of MBP-GT by MS analysis.
Chapter 4: General Conclusions and Perspectives  
      First, pgl operon of C. jejuni JCM 2013 was reconstituted in the engineered E. coli, resulted in functional prokaryotic 
N-glycosylation. Secondly, "Proof of Principle" was conducted that the early-stage eukaryotic N-glycan structure could be 
synthesized, and found glycosylated onto model protein in E. coli. For future application, design and engineering of glycan 
structure and protein secretion pathway will need to be determined. Following the Man3GlcNAc2 core structure, complex glycan 
structure could be synthesized by integration to the constructed system of eukaryote- or human-derived GTases. The culmination 
of this particular biotechnology research area will be the E. coli-synthesis of eukaryotic glycoproteins in high yield, and the 
engineering of N-glycan structures for applications of benefit to humans.
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